Subchorionic hematoma bleeding occurs when blood collects between the outer membrane surrounding the embryo (the chorion) and the uterine wall, creating a pocket of blood that can cause vaginal bleeding in early pregnancy. It is one of the most common causes of first-trimester bleeding, detected in roughly one in eight pregnancies undergoing ultrasound evaluation. Most pregnancies affected by a subchorionic hematoma go on to deliver healthy babies, but the condition does carry a measurably higher risk of miscarriage and certain later complications, and the size and timing of the hematoma matter more than many people realize.
What Actually Happens Inside the Uterus
When an embryo implants, its outermost layer, the chorion, anchors into the uterine lining. A subchorionic hematoma forms when part of this membrane partially separates from the uterine wall, and blood pools in the gap between them.1PubMed Central. Subchorionic hematoma: Research status and pathogenesis On an ultrasound, this shows up as a dark, crescent-shaped area next to the gestational sac. Sometimes the blood stays contained and is gradually reabsorbed by the body. Other times it tracks downward and exits through the cervix, which is when you see vaginal bleeding. The bleeding can range from light brown spotting, which usually means older blood, to bright red flow that looks alarmingly heavy.
Not every subchorionic hematoma produces visible bleeding. A significant number are “silent” and found incidentally during a routine ultrasound. In one study of an infertile population undergoing fertility treatment, the overall prevalence of subchorionic hematoma was about 12.5%, and among those with a hematoma, people who reported both bleeding and cramping had a dramatically higher probability of miscarriage compared to those without symptoms.2PubMed Central. Outcomes of subchorionic hematoma-affected pregnancies in the infertile population This suggests that the hematoma itself is not always the main threat; it is the combination of the hematoma with active symptoms that signals a more precarious situation.
Who Is More Likely to Develop One
Subchorionic hematomas are more common among people who conceived through in vitro fertilization. One study found the rate was about twice as high in IVF pregnancies compared to spontaneously conceived ones, roughly 22% versus 11%.3PubMed. Subchorionic hematoma occurs more frequently in in vitro fertilization pregnancy The reasons are not entirely clear, but the hormonal environment of an IVF cycle and the physical process of embryo transfer may play a role. Some researchers also suspect that the supplemental progesterone and estrogen used in many IVF protocols alter how the uterine lining responds to implantation.
Beyond IVF, other risk factors that show up in the literature include advanced maternal age, a history of recurrent miscarriage, and certain clotting disorders. Blood-thinning medications used during pregnancy, particularly the injectable anticoagulant enoxaparin, have been linked to subchorionic hematoma as a recognized complication.4Obstetrics & Gynecology. Massive Subchorionic Hematoma Associated With Enoxaparin This creates a clinical dilemma for people who need anticoagulation therapy for conditions like a history of blood clots or antiphospholipid syndrome, since the medication that protects against one risk may contribute to another.
Does the Size of the Hematoma Matter
Yes, and this is one of the most clinically meaningful details. A classic study of over 500 first-trimester pregnancies found that the overall miscarriage rate among those with a subchorionic hematoma was about 9%, but that rate nearly doubled to almost 19% when the separation was classified as large. Small and moderate hematomas had rates closer to 8% and 9%, respectively. A large hematoma carried roughly three times the risk of miscarriage compared to a small one.5PubMed. Subchorionic hemorrhage in first-trimester pregnancies: prediction of pregnancy outcome with sonography
More recent research has tried to refine how clinicians measure that size. Rather than just eyeballing the hematoma’s footprint on a flat ultrasound image, newer techniques calculate its three-dimensional volume relative to the gestational sac. One study found that the ratio of the hematoma’s volume to the gestational sac’s volume was the strongest predictor of a poor outcome, and that heavy vaginal bleeding alongside a larger volume ratio raised the odds of complications substantially.6Ultrasound Quarterly. Subchorionic Hematoma Volume Measured by Virtual Organ Computer-Aided Analysis in the Prediction of First-Trimester Pregnancy Outcome Another study identified a volume ratio threshold above which outcomes became more concerning, with the measurement achieving moderate accuracy in distinguishing pregnancies likely to have complications from those that would resolve without trouble.7PubMed Central. Diagnostic efficacy of virtual organ computer-assisted analysis in measuring the volume ratio of subchorionic hematoma with serum progesterone
The practical takeaway is that a small hematoma found incidentally on ultrasound, with no bleeding, is far less worrying than a large one accompanied by heavy vaginal bleeding. If your provider describes a hematoma as “small” or “moderate” and you have no symptoms, the statistical picture is considerably more reassuring than the diagnosis might initially sound.
Miscarriage Risk in Real Numbers
A meta-analysis that pooled data from multiple studies found that having a subchorionic hematoma roughly doubled the risk of miscarriage, with the rate going from about 9% in unaffected pregnancies to about 18% in those with a hematoma. It also found a doubled risk of stillbirth, though the baseline rate of stillbirth is much lower, going from under 1% to about 2%. To put that in a more intuitive frame, the researchers estimated that for every 11 women diagnosed with a subchorionic hematoma, one additional miscarriage would occur that would not have happened otherwise, and for stillbirth the figure was one additional case per 103 women diagnosed.8Obstetrics & Gynecology. Perinatal Outcomes in Women With Subchorionic Hematoma
A more recent large study added important nuance about timing. It found that when a hematoma was diagnosed before seven weeks of gestation, the risk of miscarriage before 20 weeks was significantly higher than when it appeared later. The timing of the hematoma’s peak size mattered too: if the hematoma reached its largest volume before seven weeks, the adjusted odds of miscarriage were over three times higher. Vaginal bleeding alongside the hematoma was independently associated with more than double the odds of pregnancy loss.9Scientific Reports. Association between first-trimester subchorionic hematoma and pregnancy loss before 20 weeks of gestation in singleton pregnancies These findings help explain why two people with the same-sized hematoma on ultrasound can have very different outcomes: when it appears and how quickly it grows or shrinks appears to matter as much as or more than sheer size alone.
When the Hematoma Appears Later in Pregnancy
Most subchorionic hematomas are discovered in the first trimester, but they can persist into or first appear during the second or third trimester. The pattern of complications shifts depending on timing. A first-trimester hematoma, while more common, generally causes fewer downstream complications if the pregnancy survives the early weeks. A hematoma that lingers into the second or third trimester is rarer but is associated with more pregnancy complications overall.10PubMed Central. Subchorionic Hematoma Association with Pregnancy Complications and Outcomes in the Third Trimester
One specific concern is preterm premature rupture of membranes, where the water breaks too early. Research has shown that severe first-trimester hematomas are associated with a higher rate of this complication, while mild or moderate hematomas are not.11Annals of Medical Research. Is a first-trimester subchorionic hematoma and its size a risk for preterm premature rupture of membranes? Miscarriage outcomes also vary by gestational age at diagnosis. One study found that miscarriage was significantly more common when the hematoma was detected before 12 weeks, while pregnancies in which the hematoma was found after 13 weeks had a significantly higher rate of reaching full term.12Zanco Journal of Medical Sciences. Pregnancy outcome in women with subchorionic haemorrhage detected in first and second trimester of pregnancy
What Can Actually Be Done About It
This is where the evidence gets frustratingly thin. There is no universally agreed-upon treatment for subchorionic hematoma. Management tends to be expectant, meaning your provider monitors you with serial ultrasounds and watches for changes. The lack of high-quality randomized controlled trials leaves practitioners relying heavily on observational data and clinical judgment.
Bed rest is commonly recommended, but its benefit remains debated. One older study found that women who adhered to bed rest had a miscarriage rate of about 10%, compared to about 23% among those who did not, along with a higher rate of reaching full term.13PubMed. Pregnancy outcome of threatened abortion with subchorionic hematoma: possible benefit of bed-rest? However, this was not a randomized trial, which means the women who rested may have differed in important ways from those who did not. The broader obstetric literature has increasingly moved away from prescribing bed rest for most pregnancy complications, since prolonged immobility carries its own risks, including blood clots and muscle loss. Many providers still suggest activity restriction as a precaution, but the honest assessment is that nobody can say with certainty whether it helps.
Progesterone supplementation is another approach sometimes used. One study of dydrogesterone, a type of progesterone, reported an abortion rate of 7% among 100 treated pregnancies, compared to a historical rate of nearly 19% in a prior group treated with a different form of progesterone.14PubMed. Subchorionic hemorrhage treatment with dydrogesterone These results are suggestive but not definitive, since comparing against a historical control group introduces significant bias. Progesterone is widely used in early pregnancy for threatened miscarriage broadly, and some providers extend its use to subchorionic hematoma cases, but the specific evidence for this indication is limited.
Medications That Complicate the Picture
If you are taking blood thinners during pregnancy, the situation becomes more complex. Enoxaparin (commonly sold as Lovenox) is prescribed during pregnancy for people with a history of blood clots or certain autoimmune conditions. Case reports and observational data have identified subchorionic hematoma as a potentially serious complication of enoxaparin use in pregnancy.15Obstetrics & Gynecology. Massive Subchorionic Hematoma Associated With Enoxaparin The concern is straightforward: a medication that reduces clotting could make a bleed between the membranes worse or harder to resolve.
However, the decision to stop or continue anticoagulation is not simple. In women with antiphospholipid syndrome, a condition where the immune system attacks proteins involved in blood clotting, one study found no significant differences in miscarriage rate, preterm birth, or live birth between those who continued anticoagulation after developing a hematoma and those who stopped, though the hematoma took longer to resolve in the group that stopped treatment.16International Journal of Women’s Health. Impact of Subchorionic Hematoma on Pregnancy Outcomes in Obstetric Antiphospholipid Syndrome For women with recurrent pregnancy loss who were taking low-dose aspirin, another study found that continuing aspirin after a hematoma diagnosis did not affect the live birth rate or how long the hematoma lasted.17PubMed Central. Impact of subchorionic hematoma on pregnancy outcomes in women with recurrent pregnancy loss These findings suggest that stopping blood thinners reflexively when a hematoma appears may not always be the right call, and the decision needs to weigh the reason the medication was started in the first place.
Can a Subchorionic Hematoma Affect Blood Test Results
This is a detail that catches many people off guard. Routine prenatal blood screening tests can be thrown off by the presence of a subchorionic hematoma, potentially leading to false alarms. One study found that patients with a hematoma had higher levels of maternal serum alpha-fetoprotein (a protein measured in standard second-trimester screening), though the elevated levels did not translate into a higher risk of neural tube defects. There was a small but statistically significant correlation between the size of the hematoma and how elevated the alpha-fetoprotein was.18Annals of Clinical and Analytical Medicine. Impact of subchorionic hematoma on maternal serum alpha-fetoprotein levels and second trimester screening outcomes in threatened abortion cases
On the other hand, first-trimester screening markers appear unaffected. A study looking at two key first-trimester blood markers, free beta-hCG and PAPP-A, found no significant differences between pregnancies with and without a subchorionic hematoma. The size of the hematoma also did not correlate with either marker.19Revista Brasileira de Ginecologia e ObstetrÃcia. Effect of subchorionic hematoma on first-trimester maternal serum free β-hCG and PAPP-A levels The practical implication is that if you had a subchorionic hematoma in the first trimester and then receive an elevated alpha-fetoprotein result in the second trimester, the hematoma may be contributing to the abnormal reading. Your provider should factor the hematoma history into how they interpret the screening result rather than jumping to more invasive follow-up testing.
What Happens to the Baby After Delivery
For pregnancies that survive past the first trimester, the question shifts from “will this pregnancy continue” to “will the baby be affected at birth.” The evidence here is somewhat reassuring but not entirely settled. An older study found that babies born after pregnancies complicated by a subchorionic hemorrhage had lower average birth weights compared to controls.20PubMed. The clinical significance of ultrasonographically detected subchorionic hemorrhages A more recent analysis, however, found no significant differences between the two groups in birth weight, gestational age at delivery, newborn illness rates, NICU admission, or Apgar scores at one minute after birth.21PubMed Central. Analysis of risk factors and pregnancy outcomes in pregnant women with subchorionic hematoma
The discrepancy between older and newer studies likely reflects improvements in prenatal monitoring and earlier detection of hematomas, including many mild ones that would not have been caught decades ago. Larger, more representative study populations in recent work also help wash out biases that may have skewed earlier, smaller studies. For most pregnancies that make it past the danger window of the first trimester, the newborn outcomes appear reassuringly similar to those of unaffected pregnancies.
The Role of Early Placental Blood Flow
Researchers have been exploring the deeper biology of why some early pregnancies develop bleeding and others do not. In a normal early pregnancy, blood flow into the space around the developing placenta increases gradually, starting at the edges and becoming more widespread by about 12 to 13 weeks. In abnormal pregnancies destined for miscarriage, this blood flow arrives earlier, is more extensive, and penetrates central regions of the placenta sooner. At 8 to 9 weeks, blood flow was detected in the vast majority of abnormal pregnancies but in fewer than half of normal ones.22Elsevier / PubMed Central. Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies
This premature flooding of the placental space with maternal blood is thought to expose the developing tissue to oxygen levels it is not yet equipped to handle, generating oxidative stress that damages the placenta. While this research does not focus exclusively on subchorionic hematoma, it offers a window into why the early pregnancy environment is so vulnerable to disruption. The partial separation of the chorion from the uterine wall that produces a hematoma may share some of these same underlying mechanisms: a mismatch between when and where blood flow arrives and when the placenta is ready for it.
Living With the Uncertainty
One of the most difficult aspects of a subchorionic hematoma diagnosis is that it lands squarely in a gray zone. The condition is common enough that many providers treat it as a nuisance rather than a crisis, yet it carries enough statistical risk that dismissing it entirely feels irresponsible. For someone experiencing active bleeding in early pregnancy, being told “it could be fine, or it might not be” is emotionally brutal even when it is medically accurate.
A few things are worth keeping in mind if you are in this situation. The majority of subchorionic hematomas resolve on their own, usually within a few weeks. The live birth rate among affected pregnancies in one large study of fertility patients was over 80%.23PubMed Central. Outcomes of subchorionic hematoma-affected pregnancies in the infertile population Serial ultrasounds are the primary monitoring tool, and a hematoma that is shrinking on successive scans is generally a good sign. Heavy bleeding with clots, cramping, and a growing hematoma on ultrasound warrant closer surveillance and a more frank conversation with your provider about what the data show for your specific circumstances.
Providers differ in how aggressively they manage this condition, partly because the evidence base for any intervention is thin. Some prescribe progesterone, some recommend reduced activity, and some do nothing beyond monitoring. None of these approaches has been convincingly proven superior in randomized trials. If you feel like your provider is not taking your concerns seriously, asking about the size of your hematoma relative to the gestational sac and the gestational age at which it was detected gives you the two data points that research has identified as most relevant to predicting how things will go.